PLD2 and colitis: The clinical phenotypes (Fig. 2A–D), indicative of disease manifestation, and the histological score (Fig. 2E,F) used to assess the extent of colon damage, showed that the knockdown of PLD2 confers protection against the development of DNBS-induced colitis, and that this protective action is neither specific nor limited to one colitis model.